Yunnan Botanee Bio-Technology Group Co.LTD (SHE:300957)
China · Delayed Price · Currency is CNY 33.29
-0.29 (-0.86%)
Jun 18, 2026, 12:29 PM CST
SHE:300957 Stock Forecast
Stock Price Forecast
According to 13 analysts polled by S&P Global, SHE:300957 stock has a consensus rating of "Buy" and an average price target of ¥46.03. The average 1-year stock price forecast is 38.27% higher than the current stock price, while the lowest is ¥34.50 (+3.63%) and the highest is ¥61.00 (+83.24%).
Price Target: ¥46.03 (+38.27%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for SHE:300957 stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 4 | 3 | 3 | 4 | 4 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 7 | 7 | 7 | 7 | 7 | 7 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 15 | 13 | 12 | 12 | 13 | 13 |
Financial Forecast
Revenue This Year
6.05B
from 5.36B
Increased by 12.89%
Revenue Next Year
6.63B
from 6.05B
Increased by 9.59%
EPS This Year
1.34
from 0.85
Increased by 57.68%
EPS Next Year
1.56
from 1.34
Increased by 16.06%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 6.3B | ||
| Avg | 6.0B | ||
| Low | 5.8B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 17.5% | ||
| Avg | 12.9% | ||
| Low | 9.2% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.47 | ||
| Avg | 1.34 | ||
| Low | 1.21 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 72.9% | ||
| Avg | 57.7% | ||
| Low | 42.4% |